Record Q2 revenue and patient growth were driven by strong performance in ventilation, sleep, and maternal health. Raised full-year revenue and EBITDA guidance, with margin improvement expected as operational investments and new systems scale.Based on Viemed Healthcare, Inc. [VMD] Q2 2026 Audio Tra…
Record quarterly revenue of $78.1 million marked a 23.9% year-over-year increase, with strong growth in ventilator and PAP therapy patient counts. Adjusted EBITDA declined slightly due to a prior-year non-recurring gain, while full-year guidance was raised on continued momentum.Original document: V…
Record Q2 2026 revenue of $78.1M marked a 24% year-over-year increase, driven by all-time high ventilator and PAP therapy patient volumes. Full-year revenue guidance was raised, with continued sequential growth and strong cash flow supporting disciplined capital allocation.Original document: Viemed…
Viemed Healthcare reported second-quarter 2026 results with revenue rising to $78.1M, up 23.9% from $63.06M a year earlier, while diluted EPS declined to $0.07 from $0.08 and net income was $2.76M compared with $3.16M in the prior-year quarter.Financial Highlights¹ Reported as “Revenue”. ² Reported…
Revenue grew 23.9% year-over-year in Q2 2026 to $78.1M, driven by expansion in rentals, sales, and services, with net income down 12.4% due to higher operating expenses and equipment disposal losses. The company remains focused on growth, diversification, and navigating regulatory changes.Original…
Record quarterly revenue of $78.1 million was achieved, with strong growth in ventilator and PAP therapy patient counts. Adjusted EBITDA was $13.7 million, and full-year guidance was raised for both revenue and capital expenditures.Original document: Viemed Healthcare, Inc. [VMD] SEC 8-K Current Re…
Viemed Healthcare reported record second-quarter 2026 net revenue of $78.1 million and net income attributable to Viemed of $2.8 million (diluted EPS $0.07). Adjusted EBITDA for the quarter totaled $13.7 million and net cash provided by operating activities was $15.9 million for the quarter. The co…
LAFAYETTE, LA / ACCESS Newswire / August 3, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") NASDAQ:VMD, a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three and…
VMD (Viemed Healthcare, Inc.) is set to announce its Q2'26 results on August 03, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 78.00 million USD with EPS (earnings per share) anticipated at 0.12 USD. Learn more details at V…
